HDM2017

DRUG3 trials

Sponsors

Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.

Conditions

CRC, Colorectal CancerColorectal Cancer MetastaticSolid Tumors

Phase 1

A Phase 1 Study of HDM2017 in Advanced Solid Tumors

RecruitingNCT07274085

Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.Solid Tumors

Start: 2025-11-18End: 2027-07-01Target: 96Updated: 2025-12-10

A Phase Ib/II Study of HDM2017 in Combination With Standard of Care in Advanced Colorectal Cancer

Not yet recruitingNCT07621159

Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.Colorectal Cancer Metastatic

Start: 2026-07-15End: 2028-11-01Target: 120Updated: 2026-06-02

A Study of HDM2017 Combination Therapy in Advanced Colorectal Cancer

RecruitingNCT07805551

Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.CRC, Colorectal Cancer

Start: 2026-08-18End: 2032-08-01Target: 220Updated: 2026-09-04